Of the shared cDC1 and cDC2 markers, the glutamine importer encoded by Slc38a2 especially caught our attention, because very recently, SLC38A2 and glutamine signaling specifically in cDC1s was shown to dictate anti-tumor immunity in vivo (45). The gene discussed is SLC38A2; the disease is neoplasm.